Published in N Engl J Med on March 14, 1985
Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011. Ann Oncol (2011) 13.95
Regional Nodal Irradiation in Early-Stage Breast Cancer. N Engl J Med (2015) 4.94
Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol (2010) 4.81
Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS. J Natl Cancer Inst (2011) 3.54
Variation in breast cancer surgery in Ontario. CMAJ (1994) 2.70
Hospital volume differences and five-year survival from breast cancer. Am J Public Health (1998) 2.57
Factors associated with the frequency of initial total mastectomy: results of a multi-institutional study. J Am Coll Surg (2013) 2.08
Benefit of semiannual ipsilateral mammographic surveillance following breast conservation therapy. Radiology (2012) 2.07
Current perceptions regarding surgical margin status after breast-conserving therapy: results of a survey. Ann Surg (2005) 2.00
Understanding of regional variation in the use of surgery. Lancet (2013) 1.97
Mastectomy or conservation: the patient's choice. BMJ (1988) 1.83
Development of a patient decision aid for choice of surgical treatment for breast cancer. Health Expect (1998) 1.48
Disparities in the Use of Breast-Conserving Therapy Among Patients With Early-Stage Breast Cancer. JAMA Surg (2015) 1.48
Addressing the psychological needs of the conservatively treated breast cancer patient: discussion paper. J R Soc Med (1987) 1.46
A survey of the management of breast cancer in England and Wales. Ann R Coll Surg Engl (1996) 1.42
Nonclinical factors associated with surgery received for treatment of early-stage breast cancer. Am J Public Health (1992) 1.42
Clinical trials and the acceptance of uncertainty. Br Med J (Clin Res Ed) (1987) 1.41
Completion of adjuvant radiation therapy among women with breast cancer. Cancer (2008) 1.39
Changes in the surgical management of early breast cancer in England. J R Soc Med (1989) 1.38
c-erbB-2 oncogene as a prognostic marker in breast cancer. Br J Cancer (1991) 1.30
American College of Surgeons Oncology Group (ACOSOG) Z0011: impact on surgeon practice patterns. Ann Surg Oncol (2012) 1.29
Institutional variation in the surgical treatment of breast cancer: a study of the NCCN. Ann Surg (2011) 1.28
Conservative treatment of early breast cancer. Long-term results of 1232 cases treated with quadrantectomy, axillary dissection, and radiotherapy. Ann Surg (1990) 1.28
Patient compliance is critical for equivalent clinical outcomes for breast cancer treated by breast-conservation therapy. Ann Surg (2000) 1.28
Emergence of stereotactic body radiation therapy and its impact on current and future clinical practice. J Clin Oncol (2014) 1.21
The validity of hospital administrative data in monitoring variations in breast cancer surgery. Am J Public Health (1996) 1.21
Choosing quality of care measures based on the expected impact of improved care on health. Health Serv Res (1992) 1.17
Racial disparities and trends in radiation therapy after breast-conserving surgery for early-stage breast cancer in women, 1992 to 2002. Ethn Dis (2007) 1.15
Treating early-stage breast cancer: hospital characteristics associated with breast-conserving surgery. Am J Public Health (1995) 1.15
Is mastectomy overused? A call for an expanded research agenda. Health Serv Res (2002) 1.14
Clinical trials in the era of personalized oncology. CA Cancer J Clin (2011) 1.13
Antiseptic toxicity to breast carcinoma in tissue culture: an adjuvant to conservation therapy? Ann R Coll Surg Engl (1990) 1.12
Mastectomy and breast reconstruction preserving the nipple. Ann R Coll Surg Engl (1990) 1.11
Quality of life measurement in breast cancer. J R Soc Med (1993) 1.08
Adjuvant radiotherapy for early breast cancer: patterns of practice in Ontario. CMAJ (1993) 1.07
The role of attitudes, beliefs, and personal characteristics of Italian physicians in the surgical treatment of early breast cancer. Am J Public Health (1991) 1.07
Quality of life after breast cancer surgery with or without reconstruction. Eplasty (2009) 1.07
The recruitment of patients to trials in head and neck cancer: a qualitative study of the EaStER trial of treatments for early laryngeal cancer. Eur Arch Otorhinolaryngol (2013) 1.03
Genetic predictors of acute toxicities related to radiation therapy following lumpectomy for breast cancer: a case-series study. Breast Cancer Res (2006) 1.01
Extreme oncoplasty: breast conservation for patients who need mastectomy. Breast J (2015) 1.01
Letrozole sensitizes breast cancer cells to ionizing radiation. Breast Cancer Res (2004) 1.01
Temporal trends in breast cancer surgery in Ontario: can one randomized trial make a difference? CMAJ (1994) 1.00
Standardized and reproducible methodology for the comprehensive and systematic assessment of surgical resection margins during breast-conserving surgery for invasive breast cancer. BMC Cancer (2009) 0.98
Recurrence dynamics does not depend on the recurrence site. Breast Cancer Res (2008) 0.97
Declining recurrence among ductal carcinoma in situ patients treated with breast-conserving surgery in the community setting. Breast Cancer Res (2009) 0.97
Is surgical management compromised in elderly patients with breast cancer? Ann Surg (1997) 0.95
Conservative treatment for breast cancer. Complications requiring reconstructive surgery. Ann Surg (1986) 0.94
What doctors tell patients with breast cancer about diagnosis and treatment: findings from a study in general hospitals. GIVIO (Interdisciplinary Group for Cancer Care Evaluation) Italy. Br J Cancer (1986) 0.94
Outcomes following local therapy for early-stage breast cancer in non-trial populations. Breast Cancer Res Treat (2010) 0.92
Retrospective comparison of non-skin-sparing mastectomy and skin-sparing mastectomy with immediate breast reconstruction. Int J Surg Oncol (2011) 0.89
Second malignancies in breast cancer patients following radiotherapy: a study in Florence, Italy. Breast Cancer Res (2011) 0.89
Non-tumour morbidity and mortality after modified radical mastectomy. Ann R Coll Surg Engl (1992) 0.89
Guideline adherence for early breast cancer before and after introduction of the sentinel node biopsy. Br J Cancer (2005) 0.89
Commentary--surgical decisions after breast cancer: can patients be too involved in decision making? Health Serv Res (2005) 0.88
The extent and distribution of cancer in breasts with palpable primary tumors. Ann Surg (1986) 0.88
Usefulness of Oncoplastic Volume Replacement Techniques after Breast Conserving Surgery in Small to Moderate-sized Breasts. Arch Plast Surg (2012) 0.88
Estimating Decision-Relevant Comparative Effects Using Instrumental Variables. Stat Biosci (2011) 0.88
Trends in breast-conserving surgery in Denmark, 1982-2002. Eur J Epidemiol (2007) 0.88
Conservative treatment of early-stage breast cancer in a medically indigent population. J Natl Med Assoc (1995) 0.87
A trial on unruptured intracranial aneurysms (the TEAM trial): results, lessons from a failure and the necessity for clinical care trials. Trials (2011) 0.86
Practice of breast self examination: disease extent at diagnosis and patterns of surgical care. A report from an Italian study. GIVIO (Interdisciplinary Group for Cancer Care Evaluation). J Epidemiol Community Health (1991) 0.86
Breast cancer outcomes among older women: HMO, fee-for-service, and delivery system comparisons. J Gen Intern Med (2001) 0.85
Wide excision of primary breast cancer: the incidence of residual carcinoma at the site of excision. Ann R Coll Surg Engl (1988) 0.85
Landmark trials affecting the surgical management of invasive breast cancer. Surg Clin North Am (2013) 0.85
The patient's appraisal of the cosmetic result of segmental mastectomy in benign and malignant breast disease. Ann Surg (1988) 0.85
The primary management of breast cancer: is breast conservation feasible for all patients? Ann R Coll Surg Engl (1989) 0.85
Sentinel Node Biopsy Alone versus Completion Axillary Node Dissection in Node Positive Breast Cancer: Systematic Review and Meta-Analysis. Int J Breast Cancer (2014) 0.85
Hypofractionated whole breast irradiation: new standard in early breast cancer after breast-conserving surgery. Radiat Oncol J (2016) 0.84
Analysis of incidence and prognostic factors for ipsilateral breast tumour recurrence and its impact on disease-specific survival of women with node-negative breast cancer: a prospective cohort study. Breast Cancer Res (2006) 0.84
Breast cancer: from "maximum tolerable" to "minimum effective" treatment. Front Oncol (2012) 0.84
Results of salvage surgery for mammary recurrence following breast-conserving therapy. Ann Surg (1988) 0.84
Changes in use of breast-conserving therapy in years 1978-2000. Br J Cancer (1994) 0.83
Progress against cancer (1971-2011): how far have we come? J Intern Med (2011) 0.83
The perspectives of Iranian physicians and patients towards patient decision aids: a qualitative study. BMC Res Notes (2013) 0.83
United States trends in the surgical treatment of primary breast cancer. World J Surg (2012) 0.83
Usefulness of a lateral thoracodorsal flap after breast conserving surgery in laterally located breast cancer. Arch Plast Surg (2013) 0.83
Breast cancer recurrence: follow up after treatment for primary breast cancer. Postgrad Med J (2004) 0.82
Imaging-assisted large-format breast pathology: program rationale and development in a nonprofit health system in the United States. Int J Breast Cancer (2012) 0.82
Biological Markers Predictive of Invasive Recurrence in DCIS. Clin Med Oncol (2008) 0.82
Randomised trial of chemotherapy versus endocrine therapy in patients presenting with locally advanced breast cancer (a pilot study). Br J Cancer (1991) 0.82
The Globalization of Cooperative Groups. Semin Oncol (2015) 0.82
Treatment of cancer in the elderly. Br J Cancer (1991) 0.81
Ipsilateral breast tumor recurrence after breast-conserving therapy: A comparison of quadrantectomy versus lumpectomy at a single institution. World J Surg (2005) 0.81
The Changing Face of Mastectomy (from Mutilation to Aid to Breast Reconstruction). Int J Surg Oncol (2011) 0.81
Pathological features of invasive breast cancer associated with a high risk of local recurrence after tumour excision and radical radiotherapy. Ann R Coll Surg Engl (1988) 0.81
Risk of contralateral breast cancer in Denmark 1943-80. Br J Cancer (1986) 0.81
Evolution of breast cancer management in Ireland: a decade of change. BMC Surg (2009) 0.81
Breast cancer surgery: who chooses and how? CMAJ (1994) 0.80
Postoperative irradiation following immediate breast reconstruction using a temporary tissue expander. J Natl Med Assoc (1994) 0.80
Ductal carcinoma in situ of the breast: a surgical perspective. Int J Surg Oncol (2012) 0.80
Predictors of nipple-areolar complex involvement by breast carcinoma: histopathologic analysis of 787 consecutive therapeutic mastectomy specimens. Ann Surg Oncol (2011) 0.80
Clinical comparison of four types of skin incisions for skin-sparing mastectomy and immediate breast reconstruction. Surg Today (2013) 0.80
Breast conservative therapy in east part of China: a retrospective cohort study. J Cancer Res Clin Oncol (2006) 0.79
Breast conserving therapy. Gland Surg (2012) 0.79
Oncoplastic volume replacement techniques according to the excised volume and tumor location in small- to moderate-sized breasts. Gland Surg (2014) 0.79
Breast cancer in the elderly. Ann Surg (1993) 0.78
"Clinical significance of multifocal and multicentric breast cancers and choice of surgical treatment: a retrospective study on a series of 1158 cases". BMC Surg (2015) 0.78
The Impacts of Breast Conserving Treatment and Mastectomy on the Quality of Life in Early-stage Breast Cancer Patients. Breast Cancer (1995) 0.78
Understanding breast cancer - The long and winding road. BBA Clin (2017) 0.77
Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst (1998) 22.10
Effect of preoperative chemotherapy on the outcome of women with operable breast cancer. J Clin Oncol (1998) 9.32
WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update. Eur Respir J (2011) 8.96
Deficient T cell fate specification in mice with an induced inactivation of Notch1. Immunity (1999) 8.33
Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial. Lancet (1999) 7.72
Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat Med (1997) 7.42
Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med (1989) 6.37
Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18. J Clin Oncol (1997) 6.35
A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors. N Engl J Med (1989) 6.24
Prevalence of Helicobacter pylori infection and histologic gastritis in asymptomatic persons. N Engl J Med (1989) 5.78
Preoperative chemotherapy in patients with operable breast cancer: nine-year results from National Surgical Adjuvant Breast and Bowel Project B-18. J Natl Cancer Inst Monogr (2001) 5.74
1-Phenylalanine mustard (L-PAM) in the management of primary breast cancer. A report of early findings. N Engl J Med (1975) 5.48
Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer. N Engl J Med (1993) 5.39
Five versus more than five years of tamoxifen therapy for breast cancer patients with negative lymph nodes and estrogen receptor-positive tumors. J Natl Cancer Inst (1996) 5.28
Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med (1995) 5.27
Detection and in situ identification of representatives of a widely distributed new bacterial phylum. FEMS Microbiol Lett (1997) 5.20
Five versus more than five years of tamoxifen for lymph node-negative breast cancer: updated findings from the National Surgical Adjuvant Breast and Bowel Project B-14 randomized trial. J Natl Cancer Inst (2001) 4.84
Comparative efficacy of adjuvant chemotherapy in patients with Dukes' B versus Dukes' C colon cancer: results from four National Surgical Adjuvant Breast and Bowel Project adjuvant studies (C-01, C-02, C-03, and C-04) J Clin Oncol (1999) 4.79
Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) eight-year update of Protocol B-17: intraductal carcinoma. Cancer (1999) 4.70
Giving patients their own records in general practice: experience of patients and staff. Br Med J (Clin Res Ed) (1986) 4.55
Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy. J Clin Oncol (1994) 4.50
Abbreviated course of radiation therapy in older patients with glioblastoma multiforme: a prospective randomized clinical trial. J Clin Oncol (2004) 4.46
Tamoxifen and chemotherapy for lymph node-negative, estrogen receptor-positive breast cancer. J Natl Cancer Inst (1997) 4.32
Qualitative research and general practice. Br J Gen Pract (1993) 4.23
Global mapping of ecosystem services and conservation priorities. Proc Natl Acad Sci U S A (2008) 4.17
Complete genome sequence of the marine planctomycete Pirellula sp. strain 1. Proc Natl Acad Sci U S A (2003) 4.16
The pathology of invasive breast cancer. A syllabus derived from findings of the National Surgical Adjuvant Breast Project (protocol no. 4). Cancer (1975) 4.12
The benefit of leucovorin-modulated fluorouracil as postoperative adjuvant therapy for primary colon cancer: results from National Surgical Adjuvant Breast and Bowel Project protocol C-03. J Clin Oncol (1993) 4.09
Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-17. J Clin Oncol (1998) 3.94
Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. An NSABP update. Cancer (1983) 3.94
Connective tissue polarity. Optical second-harmonic microscopy, crossed-beam summation, and small-angle scattering in rat-tail tendon. Biophys J (1986) 3.78
Methicillin-resistant Staphylococcus aureus. Epidemiologic observations during a community-acquired outbreak. Ann Intern Med (1982) 3.56
Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. N Engl J Med (1985) 3.41
Role of CD8(+) lymphocytes in control of simian immunodeficiency virus infection and resistance to rechallenge after transient early antiretroviral treatment. J Virol (2001) 3.40
Randomized trial of brief family interventions for general populations: adolescent substance use outcomes 4 years following baseline. J Consult Clin Psychol (2001) 3.30
Randomized trial of postoperative adjuvant chemotherapy with or without radiotherapy for carcinoma of the rectum: National Surgical Adjuvant Breast and Bowel Project Protocol R-02. J Natl Cancer Inst (2000) 3.27
Pathologic findings from the National Surgical Adjuvant Breast and Bowel Project: prognostic significance of erbB-2 protein overexpression in primary breast cancer. J Clin Oncol (1990) 3.12
The accuracy of clinical nodal staging and of limited axillary dissection as a determinant of histologic nodal status in carcinoma of the breast. Surg Gynecol Obstet (1981) 3.11
Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer: results from NSABP protocol R-01. J Natl Cancer Inst (1988) 3.09
Outcomes among African-Americans and Caucasians in colon cancer adjuvant therapy trials: findings from the National Surgical Adjuvant Breast and Bowel Project. J Natl Cancer Inst (1999) 3.07
ErbB3 is required for normal cerebellar and cardiac development: a comparison with ErbB2-and heregulin-deficient mice. Development (1997) 3.04
Direct and indirect latent-variable parenting outcomes of two universal family-focused preventive interventions: extending a public health-oriented research base. J Consult Clin Psychol (1998) 3.03
Prevention of invasive breast cancer in women with ductal carcinoma in situ: an update of the National Surgical Adjuvant Breast and Bowel Project experience. Semin Oncol (2001) 3.00
Pharmacogenetics of antidepressants and antipsychotics: the contribution of allelic variations to the phenotype of drug response. Mol Psychiatry (2004) 2.98
Cancer of the breast: size of neoplasm and prognosis. Cancer (1969) 2.91
Adjuvant therapy of Dukes' A, B, and C adenocarcinoma of the colon with portal-vein fluorouracil hepatic infusion: preliminary results of National Surgical Adjuvant Breast and Bowel Project Protocol C-02. J Clin Oncol (1990) 2.89
erbB-2 and response to doxorubicin in patients with axillary lymph node-positive, hormone receptor-negative breast cancer. J Natl Cancer Inst (1998) 2.85
Supratentorial low-grade glioma in adults: an analysis of prognostic factors and timing of radiation. J Clin Oncol (1997) 2.71
Significance of ipsilateral breast tumour recurrence after lumpectomy. Lancet (1991) 2.70